India has recorded a 38% reduction in tuberculosis (TB)-related deaths since 2015, outperforming the global decline of 35%, according to the World Health Organization's (WHO) Global Tuberculosis Report 2026. The report, released on November 12, also highlighted India's 94% treatment success rate among patients with drug-susceptible tuberculosis, reflecting progress in the country's efforts to control the infectious disease. According to the WHO, an estimated 1.13 million people died from tuberculosis worldwide in 2025, while approximately 10.6 million people developed the disease during the year. Global TB mortality declined by 4% compared with 2024. India's progress is significant, but the country continues to carry one of the world's largest tuberculosis burdens. It accounted for approximately one-quarter of all new TB cases globally in 2025, making it the country with the highest number of reported cases. The report also highlighted continuing challenges in diagnosing and treating tuberculosis, particularly drug-resistant forms of the disease. Globally, only 42% of people estimated to have rifampicin-resistant tuberculosis were started on treatment in 2025. The WHO noted that improvements in diagnosis, treatment coverage and preventive interventions remain essential to reducing the global disease burden. India's reduction in TB mortality represents progress towards the WHO End TB Strategy. However, the global target of reducing TB deaths by 90% by 2030 remains distant. The findings underline the importance of sustained screening, timely diagnosis, access to effective medicines and continued public health investment to strengthen India's tuberculosis response.
India Records 38% Decline in TB Deaths Since 2015: WHO Report
India has recorded a 38% reduction in tuberculosis-related deaths since 2015, exceeding the global average decline of 35%, according to the WHO Global Tuberculosis Report 2026. The country also reported a 94% treatment success rate among patients with drug-susceptible TB.


0 comments
No comments yet. Yours would be the first.